MYCN acts as a direct co-regulator of p53 in MYCN amplified neuroblastoma
Saurabh Agarwal(St. John's University), Jason M. Shohet(University of Massachusetts Chan Medical School)
Cited by 39
Related Papers
Repurposing of c-MET Inhibitor Tivantinib Inhibits Pediatric Neuroblastoma Cellular Growth
|Pharmaceuticals|2024|4
A Novel Druggable Dual-Specificity tYrosine-Regulated Kinase3/Calmodulin Kinase-like Vesicle-Associated Signaling Module with Therapeutic Implications in Neuroblastoma
|Biomedicines|2024|2
A novel druggable DYRK3/CAMKV signaling module for Neuroblastoma tumor growth inhibition
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0
Striking at Survivin: YM-155 Inhibits High-Risk Neuroblastoma Growth and Enhances Chemosensitivity
|Cancers|2025|0
Direct Targeting of CXCR2 Receptor Inhibits Neuroblastoma Growth: An In Vitro Assessment
|Pharmaceuticals|2025|0